Adjuvant surgery for advanced extrahepatic cholangiocarcinoma

World Journal of Gastroenterology

Volumn 19, Issue 40, 2013, Pages 6934-6938

  Oshiro, Yukio ^a   Takahashi, Kazuhiro ^a   Sasaki, Ryoko ^a   Kondo, Tadashi ^a   Sakashita, Shingo ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adjuvant surgery; Chemotherapy; Conversion surgery; Extrahepatic cholangiocarcinoma; Gemcitabine

Indexed keywords

GEMCITABINE;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; PANCREATICODUODENECTOMY; SELF EXPANDING STENT;

ADJUVANT SURGERY; CHEMOTHERAPY; CONVERSION SURGERY; EXTRAHEPATIC CHOLANGIOCARCINOMA; GEMCITABINE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; DEOXYCYTIDINE; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATICODUODENECTOMY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84887005892     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i40.6934     Document Type: Article

References (27)

1. Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128: 871-877; discussion 871-877 [PMID: 8393652]
2. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755-762 [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632.d3]
3. Sasaki R, Takahashi M, Funato O, Nitta H, Murakami M, Kawamura H, Suto T, Kanno S, Saito K. Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 2001; 129: 677-683 [PMID: 11391365 DOI: 10.1067/msy.2001.114555]
4. Oshiro Y, Sasaki R, Kobayashi A, Murata S, Fukunaga K, Kondo T, Oda T, Ohkohchi N. Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol 2011; 37: 60-64 [PMID: 21094016 DOI: 10.1016/j.ejso.2010.10.011.]
5. Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, Depisch D, Krauss G, Schneeweiss B, Scheithauer W. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 2001; 12: 183-186 [PMID: 11300321]
6. Tsavaris N, Kosmas C, Gouveris P, Gennatas K, Polyzos A, Mouratidou D, Tsipras H, Margaris H, Papastratis G, Tzima E, Papadoniou N, Karatzas G, Papalambros E. Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs 2004; 22: 193-198 [PMID: 14739669 DOI: 10.1023/B: DRUG.0000011797.09549.53]
7. Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S, Saito H, Tsuyuguchi T. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 2006; 57: 647-653 [PMID: 16142487 DOI: 10.1007/s00280-005-0095-3]
8. Union Internationale Contre le Cancer. TNM classification of malignant tumours. 7th ed. New York, NY: Wiley-Liss, 2009
9. National Institute of Health. NCI: Common Toxicity Criteria, Version 2.0. Available from: URL: http://ctep.info.nih. gov/reporting/ctc.html
10. Gerhards MF, van Gulik TM, González González D, Rauws EA, Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003; 27: 173-179 [PMID: 12616432 DOI: 10.1007/s00268-002-6434-1]
11. Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 581-587 [PMID: 10701737 DOI: 10.1016/ S0360-3016(99)00472-1]
12. Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, Goldin S, Rosemurgy P, Rosemurgy AS. Cholangiocar cinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg 2004; 70: 743-748; discussion 743-748 [PMID: 15481288]
13. McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997; 174: 605-608; discussion 605-608 [PMID: 9409582 DOI: 10.1016/ S0002-9610(97)00203-1]
14. Suzuki T, Tanabe K, Taomoto J, Yamamoto H, Tokumoto N, Yoshida K, Ohdan H. Preliminary trial of adjuvant surgery for advanced gastric cancer. Oncol Lett 2010; 1: 743-747 [PMID: 22966373]
15. Power DG, Kemeny NE. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection. Crit Rev Oncol Hematol 2011; 79: 251-264 [PMID: 20970353 DOI: 10.1016/j.critrevonc.2010.08.001]
16. Kato K, Kondo S, Hirano S, Tanaka E, Shichinohe T, Tsuchikawa T, Matsumoto J. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. J Hepatobiliary Pancreat Sci 2011; 18: 712-716 [PMID: 21455748 DOI: 10.1007/ s00534-011-0391-8]
17. Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kimura F, Miyazaki M. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surg Oncol 2013; 20: 318-324 [PMID: 23149849 DOI: 10.1245/s10434-012-2312-8]
18. Slupski MW, Szczylik C, Jasinski MK. Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma. World J Surg Oncol 2007; 5: 36 [PMID: 17376238 DOI: 10.1186/1477-7819-5-36]
19. Shirabe K, Tomoyuki Abe Kiyoshi Kajiyama, Kazuya Akahoshi. [The Survival Impact of Chemotherapy in the Patients with Gall Bladder Cancer-A pilot study]. J Jpn Biliary Association 2008; 22: 41-46
20. Kitajima K, Kobayashi S, Shiba H, Uwagawa T, Ishida Y, Aiba K, Kawakami M, Yanaga K. Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene. Int J Clin Oncol 2008; 13: 545-551 [PMID: 19093184 DOI: 10.1007/s10147-008-0777-z]
21. Morimoto H, Ajiki T, Takase S, Fujita T, Matsumoto T, Mita Y, Matsumoto I, Fujino Y, Suzuki Y, Kuroda Y, Ku Y. Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine. J Hepatobiliary Pancreat Surg 2008; 15: 655-658 [PMID: 18987939 DOI: 10.1007/s00534-007-1311-9]
22. Kanaji S, Kobayashi I, Fujita T, Ueno K, Tsuchida S, Kawasaki K, Ohno M, Osawa M, Fujino Y, Tominaga M, Nakamura T. [A case of curatively resected biliary tract cancer with peritoneal dissemination through effective response to chemotherapy of S-1]. Gan To Kagaku Ryoho 2009; 36: 1337-1339 [PMID: 19692774]
23. Kim SH, Kim IH, Kim SW, Lee SO. Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma. World J Gastroenterol 2009; 15: 4593-4595 [PMID: 19777621 DOI: 10.3748/wjg.15.4593]
24. Ohno T, Koguchi H, Miura A, Tanaka Y, Endo M, Matsunaga S, Hasegawa I, Kato A, Tokuda Y, Sakakibara K. [A case of advanced ampullary carcinoma successfully resected after primary chemotherapy with s-1 and gemcitabine]. Gan To Kagaku Ryoho 2009; 36: 999-1002 [PMID: 19542724]
25. Hasegawa N, Abei M, Sasaki R, Pak S, Moriwaki T, Minami Y, Fukuda K, Hirai S, Shoda J, Ohkouchi N, Hyodo I. [A case with Stage IVb advanced gallbladder cancer curatively resected following effective S-1 chemotherapy]. J Jpn Biliary Association 2010; 24: 723-728
26. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-1281 [PMID: 20375404 DOI: 10.1056/NEJMoa0908721]
27. Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, Nagino M, Kondo S, Nagaoka S, Funai J, Koshiji M, Nambu Y, Furuse J, Miyazaki M, Nimura Y. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 2010; 103: 469-474 [PMID: 20628385 DOI: 10.1038/sj.bjc.6605779]